Hospitals without on-site cardiac surgery can perform non-emergency angioplasty safely and effectively
(Medical Xpress) -- Patients who have non-emergency angioplasty to open blocked heart vessels have no greater risk of death or complications when they have the procedure at hospitals without cardiac surgery backup. That is the conclusion of a national a study to assess the safety and effectiveness of such procedures at community hospitals.
Results of the study, called the Cardiovascular Patient Outcomes Research Team Elective Angioplasty Study (C-PORT-E), are being presented on March 25 at the American College of Cardiology (ACC) annual meeting in Chicago. The study also will be published online by the New England Journal of Medicine to coincide with the ACC presentation.
The study, led by Johns Hopkins cardiologist Thomas Aversano, evaluated the nine-month outcomes of 18,867 patients who were randomly assigned to have elective heart artery-opening angioplasty or stenting at hospitals with or without cardiac surgery capability.
Our composite endpoints in the studydeath, heart attack, and blockage again in the vessel that was opened with angioplastyshowed similar results at nine months whether the procedure was performed at a hospital with or without cardiac surgery backup, says Aversano, who is an associate professor of medicine at the Johns Hopkins University School of Medicine.
He says that there was a small difference among the two groups regarding the need for revascularizationa second procedure to open the same vessel.
We found that more patients treated at community hospitals without surgery backup required a repeat procedure within 9 months. The size of the difference in repeat procedure rates between hospitals with and without on-site cardiac surgery is small, between 11 and 17 additional procedures for every 1,000 treated patients. He adds, The reason for the difference is not clear except that it may reflect a more conservative approach at treating the blockage among interventional cardiologists at hospitals without cardiac surgery capability.
The study included 60 hospitals in 10 states without cardiac surgery backup. In order to participate in the study, those hospitals had to perform a minimum of 200 angioplasty procedures each year and develop a formal angioplasty development program to prepare their staff and establish protocols and policies.
Emergency angioplasty is performed during a heart attack, when a vessel needs to be opened right away to restore blood flow in the heart. Non-emergency procedures are offered to patients with blockages that may be causing chest pain.
During angioplasty, a tiny balloon is inflated within a coronary artery to push away plaque that is causing a blockage in the vessel. Stents, which act like tiny scaffolds, also can be put in place to keep the artery open. In rare cases, the procedure can cause a tear in the vessel or closing of the artery, requiring open heart surgery to repair the problem.
Until a recent change in guidelines by the American College of Cardiology and the American Heart Association, non-emergency angioplasty was not recommended at community hospitals without cardiac surgery backup in case there were complications that required emergency surgery. Dr. Aversano says results of the study support the change in the guidelines.
The researchers do not believe that every hospital should be performing angioplasty. However, they wanted to know if hospitals that already offer emergency angioplasty to open blocked coronary arteries in heart attack patients can also safely and effectively perform elective angioplasty.
About 850,000 angioplasties are performed in the United States each year. The goal of our study, says Aversano, is to give health care planners the best possible information on which to base their decisions about the allocation of resources, so that patients can have access to the highest quality of care.
The CPORT study centers, which include Johns Hopkins, Duke University and Clinical Trials and Surveys Corp. (formerly the Maryland Medical Research Institute), are funded by the hospitals participating in the study.
Provided by
Johns Hopkins University
-
Patients fare just as well if their nonemergency angioplasty is performed at hospitals
Nov 14, 2011 |
not rated yet |
0
-
Safety in numbers for community hospitals performing emergency angioplasty
Nov 13, 2008 |
not rated yet |
0
-
Angioplasties performed at centers without on-site surgery services are safe, study finds
Dec 13, 2011 |
not rated yet |
0
-
Most hospitals miss critical window for heart attack transfer patients
Nov 28, 2011 |
not rated yet |
0
-
Tears during coronary angioplasty: Where are they and how do they affect patient outcomes?
Mar 24, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
what is the distance traveled
59 minutes ago
-
Image of a Convex Lens Cut in Half Horizontally
4 hours ago
-
Ray tracing throught optical system of thick lenses
5 hours ago
-
Faraday's law on circular wire
5 hours ago
-
Specific Exergy vs Specific Flow Exergy
7 hours ago
-
The Durability of Bone: Long Falls
15 hours ago
- More from Physics Forums - Classical Physics
More news stories
Costs to treat stroke in America may double by 2030
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
Cardiology
1 hour ago |
not rated yet |
0
New blood-thinner measures may cut medication errors
Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...
Cardiology
4 hours ago |
not rated yet |
0
Registry questions superiority of bivalirudin over heparin
Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...
Cardiology
4 hours ago |
not rated yet |
0
Study shows low rate of late lumen loss with bioresorbable DESolve device
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...
Cardiology
4 hours ago |
not rated yet |
0
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
20 hours ago |
5 / 5 (1) |
0
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Research shows how immune system peacefully co-exists with 'good' bacteria
The human gut is loaded with commensal bacteria – "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the ...
AIDS scientists optimistic of AIDS cure, for some
Top AIDS scientists were optimistic Wednesday of finding a cure for the disease that has claimed 30 million lives—but said it might not work for all people.
Fish oil supplements may help fight against Type 2 diabetes
Widely-used fish oil supplements modestly increase amounts of a hormone that is associated with lower risk of diabetes and heart disease, according to a study accepted for publication in The Endocrine Society's Journal of ...
Fish oil may help the heart beat mental stress
Why is fish oil good for the heart? A new study suggests that this omega 3 fatty acid-rich nutrient could blunt some cardiovascular effects of mental stress.